ViaLase CEO talks innovations in glaucoma treatment

Video
Conferences|ASCRS

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

See more ASCRS coverage

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
ChatGPT may have a future use in glaucoma

ChatGPT may have a future use in glaucoma

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Nicox announces recruitment of last patient in US in Denali Phase 3 trial of NCX 470

Nicox announces recruitment of last patient in US in Denali Phase 3 trial of NCX 470

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
Spryte Medical neuro OCT receives Breakthrough Device Designation by FDA

Spryte Medical neuro OCT receives Breakthrough Device Designation by FDA

Article
Clinical trial recruitment and AI: Easing the burden of GA studies

Clinical trial recruitment and AI: Easing the burden of GA studies

Article
© 2024 MJH Life Sciences

All rights reserved.